| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 3623.16 | 3171.61 | 2683.04 | 2422.50 | 2211.56 | 679.18 | 404.22 |
| Depreciation & Amort ($Mil): | 380.29 | 380.29 | 375.87 | 402.20 | 439.43 | 61.30 | 10.15 |
| Operating Income ($Mil): | 1383.69 | 1135.15 | 1005.20 | 656.45 | 391.09 | -13.48 | 213.87 |
| Net Income ($Mil): | 690.26 | 638.17 | 217.51 | 160.71 | 25.08 | 148.09 | 148.09 |
| Earnings Per Share ($): | 2.32 | 1.99 | 0.63 | 0.46 | 0.13 | -4.92 | 0.85 |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 2161.02 | 2368.40 | 1712.56 | 1618.08 | 1931.04 | 1838.66 | 977.61 |
| Current Liabilities ($Mil): | 885.44 | 2189.17 | 582.85 | 583.03 | 1260.74 | 404.82 | 56.22 |
| Long Term Debt ($Mil): | 1038.08 | 51.84 | 96.69 | 43.44 | 101.87 | 887.27 | 866.20 |
| Shares Outstanding (000): | 290300 | 293370 | 337130 | 339410 | 333550 | 327600 | 153030 |
| Common Equity ($Mil): | 5522.93 | 5534.29 | 7149.77 | 6905.87 | 6826.40 | 7053.32 | 1109.69 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | 19.05 | 20.12 | 8.11 | 6.63 | 1.13 | -128.85 | 36.64 |
| Return on Equity (%): | 17.40 | 11.53 | 3.04 | 2.33 | 0.37 | -12.41 | 13.35 |
| Return on Assets (%): | 11 | 7.40 | 2.54 | 1.92 | 0.27 | -9.21 | 7.19 |
| P/E Ratio: | 16 | 28.44 | 73.02 | 94.07 | 440.38 | -7.00 | 0.00 |
| Price/Book: | 3 | 3.00 | 2.17 | 2.13 | 2.80 | 1.60 | 0.00 |
| Debt Equity: | 0.19 | 0.01 | 0.01 | 0.01 | 0.01 | 0.13 | 0.78 |
| Interest Coverage: | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.41 |
| Book Value ($): | 19.02 | 18.86 | 21.21 | 20.35 | 20.47 | 21.53 | 7.25 |
| Price/Sales: | 5.64 | 3.86 | 5.78 | 6.06 | 8.63 | 16.61 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |


| AMGEN | +30.20 | 60.88 | |
| AMYLIN PHARMA I | -55.90 | 21.48 | |
| GILEAD SCIENCES | +22.60 | 49.98 | |
| BIOGEN IDEC INC | -21.40 | 48.16 | |
| GENENTECH INC | +33.70 | 96.50 |
